Literature DB >> 20012312

Autosomal dominant nemaline myopathy caused by a novel alpha-tropomyosin 3 mutation.

I C Kiphuth, S Krause, H B Huttner, G Dekomien, T Struffert, R Schröder.   

Abstract

Nemaline myopathy (NM) is a genetically and clinically heterogenous muscle disorder, which is myopathologically characterized by nemaline bodies. Mutations in six genes have been reported to cause NM: Nebulin (NEB Pelin 1999), alpha-skeletal muscle actin (ACTA1 Nowak 1999), alpha-slow tropomyosin (TPM3 Laing 1995), beta-tropomyosin (TPM2 Donner 2002), slow troponin T (TNNT1 Johnston 2000) and cofilin 2 (CFL2 Agrawal 2007). The majority of cases are due to mutation in NEB and ACTA1. We report on the clinical, myopathological and muscle MRI findings in a German family with autosomal dominant NM due to a novel pathogenic TPM3 mutation (p.Ala156Thr).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012312     DOI: 10.1007/s00415-009-5413-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  NEMALINE MYOPATHY. A NEW CONGENITAL MYOPATHY.

Authors:  G M SHY; W K ENGEL; J E SOMERS; T WANKO
Journal:  Brain       Date:  1963-12       Impact factor: 13.501

2.  TPM3 mutation in one of the original cases of cap disease.

Authors:  Monica Ohlsson; Anna Fidzianska; Homa Tajsharghi; Anders Oldfors
Journal:  Neurology       Date:  2009-06-02       Impact factor: 9.910

3.  Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Authors:  Nigel G Laing; Danielle E Dye; Carina Wallgren-Pettersson; Gabriele Richard; Nicole Monnier; Suzanne Lillis; Thomas L Winder; Hanns Lochmüller; Claudio Graziano; Stella Mitrani-Rosenbaum; Darren Twomey; John C Sparrow; Alan H Beggs; Kristen J Nowak
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

4.  A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy.

Authors:  N G Laing; S D Wilton; P A Akkari; S Dorosz; K Boundy; C Kneebone; P Blumbergs; S White; H Watkins; D R Love
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

5.  Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin.

Authors:  Vilma-Lotta Lehtokari; Katarina Pelin; Kati Donner; Thomas Voit; Sabine Rudnik-Schöneborn; Mechthild Stoetter; Beril Talim; Haluk Topaloglu; Nigel G Laing; Carina Wallgren-Pettersson
Journal:  Eur J Hum Genet       Date:  2008-04-02       Impact factor: 4.246

6.  Mutations in TPM3 are a common cause of congenital fiber type disproportion.

Authors:  Nigel F Clarke; Hanna Kolski; Danielle E Dye; Esther Lim; Robert L L Smith; Rakesh Patel; Michael C Fahey; Rémi Bellance; Norma B Romero; Edward S Johnson; Annick Labarre-Vila; Nicole Monnier; Nigel G Laing; Kathryn N North
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

7.  Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy.

Authors:  D Wattanasirichaigoon; K J Swoboda; F Takada; H-Q Tong; V Lip; S T Iannaccone; C Wallgren-Pettersson; N G Laing; A H Beggs
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

8.  Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy.

Authors:  Vilma-Lotta Lehtokari; Katarina Pelin; Maria Sandbacka; Salla Ranta; Kati Donner; Francesco Muntoni; Caroline Sewry; Corrado Angelini; Kate Bushby; Peter Van den Bergh; Susan Iannaccone; Nigel G Laing; Carina Wallgren-Pettersson
Journal:  Hum Mutat       Date:  2006-09       Impact factor: 4.878

  8 in total
  13 in total

1.  Clinical utility gene card for: nemaline myopathy.

Authors:  Kristen J Nowak; Mark R Davis; Carina Wallgren-Pettersson; Phillipa J Lamont; Nigel G Laing
Journal:  Eur J Hum Genet       Date:  2012-04-18       Impact factor: 4.246

2.  Clinical utility gene card for: Nemaline myopathy - update 2015.

Authors:  Kristen J Nowak; Mark R Davis; Carina Wallgren-Pettersson; Phillipa J Lamont; Nigel G Laing
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

3.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

4.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

5.  Neuromuscular disorders and 2010: recent advances.

Authors:  Anna Sarkozy; Hanns Lochmüller
Journal:  J Neurol       Date:  2010-09-18       Impact factor: 4.849

6.  Skeletal muscle myopathy mutations at the actin tropomyosin interface that cause gain- or loss-of-function.

Authors:  Massimiliano Memo; Steven Marston
Journal:  J Muscle Res Cell Motil       Date:  2013-05-30       Impact factor: 2.698

7.  Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patients.

Authors:  Steven Marston; Massimiliano Memo; Andrew Messer; Maria Papadaki; Kristen Nowak; Elyshia McNamara; Royston Ong; Mohammed El-Mezgueldi; Xiaochuan Li; William Lehman
Journal:  Hum Mol Genet       Date:  2013-07-25       Impact factor: 6.150

8.  Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.

Authors:  Michaela Yuen; Sandra T Cooper; Steve B Marston; Kristen J Nowak; Elyshia McNamara; Nancy Mokbel; Biljana Ilkovski; Gianina Ravenscroft; John Rendu; Josine M de Winter; Lars Klinge; Alan H Beggs; Kathryn N North; Coen A C Ottenheijm; Nigel F Clarke
Journal:  Hum Mol Genet       Date:  2015-08-24       Impact factor: 6.150

9.  The R168G heterozygous mutation of tropomyosin 3 (TPM3) was identified in three family members and has manifestations ranging from asymptotic to serve scoliosis and respiratory complications.

Authors:  Haoyue Xu; Hang Liu; Tao Chen; Bo Song; Jin Zhu; Xing Liu; Ming Li; Cong Luo
Journal:  Genes Dis       Date:  2020-01-25

10.  Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism.

Authors:  Charlotte Gineste; Guillaume Duhamel; Yann Le Fur; Christophe Vilmen; Patrick J Cozzone; Kristen J Nowak; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.